Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Enterprise Value of -$143.9 million for Q1 2026, up 65.96% on a QoQ basis from -$422.6 million in Q4 2025, and up 53.95% year-over-year from -$93.4 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Enterprise Value (2019 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Enterprise Value history runs 8 years deep, the most recent figure standing at -$143.9 million for Q1 2026.
- Quarterly Enterprise Value rose 53.95% year-over-year to -$143.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$143.9 million (up 53.95% YoY) and the FY2025 annual result came in at -$422.6 million, up 24.74% from the prior year.
- Enterprise Value was -$143.9 million for Q1 2026 at Ginkgo Bioworks Holdings, up from -$422.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$111.1 million in Q3 2025 and bottomed at -$1.5 billion in Q1 2022.
- A 5-year average of -$805.0 million and a median of -$840.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 472.73% — and 2025, when it surged 81.98%.
- Ginkgo Bioworks Holdings' Enterprise Value stood at -$1.3 billion in 2022, then advanced by 28.36% to -$944.1 million in 2023, then jumped by 40.52% to -$561.6 million in 2024, then rose by 24.74% to -$422.6 million in 2025, then surged by 65.96% to -$143.9 million in 2026.
- Business Quant data shows DNA's Enterprise Value at -$143.9 million in Q1 2026, -$422.6 million in Q4 2025, and -$111.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -143.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.86 Mn |
| Dec 31, 2025 | -422.62 Mn |
| Sep 30, 2025 | -111.07 Mn |
| Jun 30, 2025 | -203.57 Mn |
| Mar 31, 2025 | -312.42 Mn |
| Dec 31, 2024 | -561.57 Mn |
| Sep 30, 2024 | -616.21 Mn |
| Jun 30, 2024 | -730.37 Mn |
| Mar 31, 2024 | -840.44 Mn |
| Dec 31, 2023 | -944.07 Mn |
| Sep 30, 2023 | -1.05 Bn |
| Jun 30, 2023 | -1.11 Bn |
| Mar 31, 2023 | -1.21 Bn |
| Dec 31, 2022 | -1.32 Bn |
| Sep 30, 2022 | -1.30 Bn |
| Jun 30, 2022 | -1.35 Bn |
| Mar 31, 2022 | -1.47 Bn |
| Dec 31, 2021 | -1.50 Bn |
| Sep 30, 2021 | -1.68 Bn |
| Jun 30, 2021 | -235.89 Mn |